SARS-CoV-2 test - 92 % sensitivity and 98.5 % specificity

Product information

The first internal evaluation of the SARS-CoV-2 test was performed on 100 positive and 500 negative samples with 92% sensitivity and 98.5% specificity. Subsequent external and independent evaluation was conducted at the University of Wroclaw (Life sciences), Poland. 30 positive and 30 negative SARS-CoV-2 samples were analyzed with 90 % sensitivity and 97 % specificity compared to standard PCR.

SARS-cov-2-os5to9qto4ymhptznc4ag9q96qrbyfui2excx04yt4

SensDx products

$

Mobi SensDx

Mobi SensDx is the base for SensDx's technology. It is a multi-purpose diagnostic platform.

$

Flu SensDx

This product was launched in Poland in the autumn of 2019, and is already used at 100 doctors' offices and hospitals in the country.

$

SARS-CoV-2 test

The first internal evaluation of the SARS-CoV-2 test was performed on 100 positive and 500 negative samples with 92 % sensitivity and 98.5 % specificity.

$

Products under development

It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.

$

Products under development

It is continuously researched and developed with the expansion of the product portfolio. Here are some products we have under development.